CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Eton Pharmaceuticals Files FDA Supplement Seeking to Expand KHINDIVI Pediatric Indication

NDA FilingKHINDIVIPositive
AI Analysis

Summary

Eton Pharmaceuticals has filed an FDA supplement to expand KHINDIVI to a pediatric indication. The filing represents a routine regulatory action seeking label expansion for the existing drug.

Importance:5/10
Sentiment:
0.30
FDAsupplementindication expansionpediatric
Related Companies

Read the original article

Published by yahoo_finance on July 29, 2026 1:54 PM

Read Original